CRISPR Therapeutics
CRSP
CRSP
179 hedge funds and large institutions have $1.01B invested in CRISPR Therapeutics in 2018 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 39 closing their positions.
Holders
179
Holders Change
+5
Holders Change %
+2.87%
% of All Funds
4.1%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
44
Increased
49
Reduced
40
Closed
39
Calls
$20.2M
Puts
$46.7M
Net Calls
-$26.5M
Net Calls Change
+$30.6M